Can a patient safely take Strattera (atomoxetine) and sertraline together with Concerta (methylphenidate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can You Take Strattera and Sertraline Together with Concerta?

Yes, you can safely take Strattera (atomoxetine), sertraline, and Concerta (methylphenidate) together, but this combination requires careful monitoring for serotonin syndrome and cardiovascular effects.

Key Safety Considerations

Serotonin Syndrome Risk

The primary concern with this combination is serotonin syndrome, as you're combining multiple serotonergic medications. The 2020 AACAP guidelines specifically note that caution should be exercised when combining two or more non-MAOI serotonergic drugs, including SSRIs (like sertraline) and stimulants (including "possibly methylphenidate classes") 1.

Critical warning signs to monitor (especially in first 24-48 hours after starting or dose changes):

  • Mental status changes: confusion, agitation, anxiety
  • Neuromuscular hyperactivity: tremors, muscle rigidity, hyperreflexia, clonus
  • Autonomic instability: hypertension, tachycardia, diaphoresis, fever

Important caveat: While methylphenidate is mentioned as "possibly" contributing to serotonin syndrome risk, the evidence is less robust compared to amphetamines. The guidelines emphasize this is more theoretical than proven 1.

Cardiovascular Monitoring

Both Concerta and Strattera affect cardiovascular parameters:

  • Concerta increases blood pressure and heart rate 2
  • Strattera can increase heart rate and blood pressure 3
  • Sertraline has minimal cardiovascular effects but can interact with drugs metabolized by CYP2D6 1, 4

Monitor blood pressure and pulse regularly, especially during initiation and dose adjustments 3, 5.

Evidence Supporting This Combination

Atomoxetine + Methylphenidate

Multiple studies demonstrate this combination is safe and can be effective:

  • A 2013 systematic review found no serious adverse events when combining stimulants with atomoxetine 6
  • A 2015 study of 12 patients showed significant improvement with combined methylphenidate and atomoxetine, with common side effects being irritability (41.6%), appetite reduction (25%), and palpitations (16.7%) 7
  • A 2007 pilot study found methylphenidate appears to be safely combined with atomoxetine, though the sample was small 8

Atomoxetine + SSRIs

  • A 2005 study specifically examined atomoxetine combined with fluoxetine (another SSRI like sertraline) in children/adolescents with ADHD and comorbid depression/anxiety. The combination was well tolerated, though it showed greater increases in blood pressure and pulse compared to atomoxetine alone 9

Methylphenidate + SSRIs

  • A 2024 large cohort study (17,234 adults) found no significant increase in adverse events when combining methylphenidate with SSRIs compared to methylphenidate alone. In fact, the combination was associated with a lower risk of headache 10

Practical Management Algorithm

1. Start low, go slow:

  • Begin the second serotonergic drug at a low dose
  • Increase doses slowly with close monitoring 1

2. Monitor intensively in first 48 hours after:

  • Starting any of these medications
  • Any dose increases
  • Watch specifically for serotonin syndrome symptoms

3. Regular cardiovascular checks:

  • Baseline blood pressure and heart rate before starting
  • Monitor at each dose adjustment
  • Periodic monitoring during maintenance

4. Watch for behavioral activation:

  • More common in younger patients
  • Can occur with SSRIs, especially early in treatment or with dose increases
  • May be difficult to distinguish from ADHD symptoms 1

5. Drug interactions to consider:

  • Sertraline may interact with drugs metabolized by CYP2D6 1
  • This is generally not clinically significant with atomoxetine or methylphenidate

Common Pitfalls to Avoid

  1. Don't assume all stimulants carry equal serotonin syndrome risk - methylphenidate's risk is lower and more theoretical than amphetamines
  2. Don't overlook cardiovascular monitoring - both ADHD medications affect BP/HR
  3. Don't miss early serotonin syndrome signs - agitation and anxiety can be mistaken for ADHD or anxiety symptoms
  4. Don't forget to educate the patient/family about warning signs to report immediately

Contraindications

Absolute contraindications from FDA labeling:

  • Current or recent (within 2 weeks) MAOI use with either Concerta or sertraline 4, 2
  • Known hypersensitivity to any component
  • Uncontrolled hypertension or serious cardiac disease (for Concerta) 2

Bottom line: This three-drug combination is used in clinical practice and supported by evidence showing safety when properly monitored. The theoretical serotonin syndrome risk requires vigilance but should not prevent appropriate treatment of comorbid ADHD and depression/anxiety when clinically indicated.

References

Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Research

Combined methylphenidate and atomoxetine pharmacotherapy in attention deficit hyperactivity disorder.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2015

Research

Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms.

Journal of the American Academy of Child and Adolescent Psychiatry, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.